Skip to main content
. 2022 Jun 29;11(13):e025565. doi: 10.1161/JAHA.122.025565

Figure 4. Changes in SUVmax during steroid therapy in patients with subsequent FDG‐PET evaluation.

Figure 4

Box plots with median and interquartile range of the observed data obtained at baseline and subsequent evaluation after steroid therapy. Error bars represent 95% CIs. The regression line was obtained using a mixed‐model approach. SUVmax significantly improved at subsequent follow‐up in CS (P<0.001; A) and isolated CS (P=0.024; B). CS indicates cardiac sarcoidosis, and SUVmax, maximum standardized uptake value.